AI assistant
Sending…
BICYCLE THERAPEUTICS PLC — Director's Dealing 2023
Jan 6, 2023
32777_dirs_2023-01-05_33c3b417-6fe8-4e0b-92ca-fe562285187c.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: BICYCLE THERAPEUTICS plc (BCYC)
CIK: 0001761612
Period of Report: 2023-01-03
Reporting Person: Kender Richard N (Director)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2023-01-03 | Ordinary Shares | A | 5750 | $0.00 | Acquired | 10750 | Direct |
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2023-01-03 | Stock Option (right to buy) | $29.60 | A | 11500 | Acquired | 2033-01-03 | Ordinary Shares (11500) | Direct |
Footnotes
F1: Represents a restricted stock unit ("RSU") award. The RSUs shall vest in four equal installments on March 15, 2023, June 15, 2023, September 15, 2023 and December 15, 2023.
F2: Each RSU represents a contingent right to receive one ordinary share.
F3: This option shall vest in four equal installments on March 15, 2023, June 15, 2023, September 15, 2023 and December 15, 2023.
More from BICYCLE THERAPEUTICS PLC
Regulatory Filings
2026
May 21
Interim / Quarterly Report
2026
Apr 30
Earnings Release
2026
Apr 30
Regulatory Filings
2026
Apr 20
Director's Dealing
2026
Mar 25
Annual Report
2026
Mar 17
Board/Management Information
2026
Mar 17
Major Shareholding Notification
2026
Feb 11
Director's Dealing
2026
Feb 4
Board/Management Information
2026
Feb 3